Literature DB >> 22948538

Treatment patterns and outcomes in elderly patients with multiple myeloma.

S-M Bang, R A Kyle, S V Rajkumar, S Kumar.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22948538      PMCID： PMC3921975          DOI： 10.1038/leu.2012.259

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  13 in total

1.  A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK.

Authors:  K J Phekoo; S A Schey; M A Richards; D H Bevan; S Bell; D Gillett; H Møller
Journal:  Br J Haematol       Date:  2004-11       Impact factor: 6.998

2.  Treatment of multiple myeloma in elderly people: long-term results in 178 patients.

Authors:  J Bladé; M Muñoz; M Fontanillas; J San Miguel; A Alcalá; J Maldonado; C Besses; M J Moro; J García-Conde; C Rozman; E Montserrat; J Estapé
Journal:  Age Ageing       Date:  1996-09       Impact factor: 10.668

3.  Multiple myeloma in a young woman.

Authors:  V Clough; I W Delamore; J A Whittaker
Journal:  Ann Intern Med       Date:  1977-01       Impact factor: 25.391

4.  Multiple myeloma in the geriatric patient.

Authors:  P Froom; M Quitt; E Aghai
Journal:  Cancer       Date:  1990-09-01       Impact factor: 6.860

5.  Age and clinical decision making in oncology patients.

Authors:  S B Yellen; D F Cella; W T Leslie
Journal:  J Natl Cancer Inst       Date:  1994-12-07       Impact factor: 13.506

6.  Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial.

Authors:  Cyrille Hulin; Thierry Facon; Philippe Rodon; Brigitte Pegourie; Lotfi Benboubker; Chantal Doyen; Mamoun Dib; Gaelle Guillerm; Bruno Salles; Jean-Paul Eschard; Pascal Lenain; Philippe Casassus; Isabelle Azaïs; Olivier Decaux; Laurent Garderet; Claire Mathiot; Jean Fontan; Ingrid Lafon; Jean Marc Virion; Philippe Moreau
Journal:  J Clin Oncol       Date:  2009-05-18       Impact factor: 44.544

Review 7.  Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma.

Authors:  R A Kyle; S V Rajkumar
Journal:  Leukemia       Date:  2008-10-30       Impact factor: 11.528

8.  Multiple myeloma presenting as primary non-secretory plasma cell leukemia.

Authors:  Jitender Mohan Khunger; Mukesh Sharma; V H Talib
Journal:  Indian J Pathol Microbiol       Date:  2003-01       Impact factor: 0.740

9.  Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003.

Authors:  Sigurdur Yngvi Kristinsson; Ola Landgren; Paul W Dickman; Asa Rangert Derolf; Magnus Björkholm
Journal:  J Clin Oncol       Date:  2007-04-09       Impact factor: 44.544

Review 10.  Too old to care?

Authors:  Richard T Penson; Kristy J Daniels; Thomas J Lynch
Journal:  Oncologist       Date:  2004
View more
  5 in total

Review 1.  Managing multiple myeloma in elderly patients.

Authors:  Evan Diamond; Oscar B Lahoud; Heather Landau
Journal:  Leuk Lymphoma       Date:  2017-08-28

Review 2.  Management of Newly Diagnosed Elderly Multiple Myeloma Patients.

Authors:  Crystal Antoine-Pepeljugoski; Marc Justin Braunstein
Journal:  Curr Oncol Rep       Date:  2019-05-24       Impact factor: 5.075

3.  Clinical impacts of frailty, poor performance status, and advanced age in carfilzomib-containing treatment for relapsed/refractory multiple myeloma: post hoc investigation of the KOTOSG multicenter pilot prospective observational study.

Authors:  Yuka Kawaji-Kanayama; Ayako Muramatsu; Nana Sasaki; Kazuho Shimura; Miki Kiyota; Shinichi Fuchida; Reiko Isa; Takahiro Fujino; Yayoi Matsumura-Kimoto; Taku Tsukamoto; Yoshiaki Chinen; Shinsuke Mizutani; Mitsushige Nakao; Hiroto Kaneko; Eri Kawata; Koichi Hirakawa; Ryoichi Takahashi; Chihiro Shimazaki; Hitoji Uchiyama; Nobuhiko Uoshima; Yuji Shimura; Tsutomu Kobayashi; Masafumi Taniwaki; Junya Kuroda
Journal:  Int J Hematol       Date:  2022-01-24       Impact factor: 2.490

4.  Multiple Myeloma in Patients over 80: A Real World Retrospective Study of First Line Conservative Approach with Bortezomib Dexamethasone Doublet Therapy and Mini-Review of Literature.

Authors:  Laurence Huynh; Rudy Birsen; Lucie Mora; Anne-Laure Couderc; Nathalie Mitha; Anaïs Farcet; Amale Chebib; Pascal Chaibi
Journal:  Cancers (Basel)       Date:  2022-09-28       Impact factor: 6.575

Review 5.  Review of health-related quality of life data in multiple myeloma patients treated with novel agents.

Authors:  P Sonneveld; S G Verelst; P Lewis; V Gray-Schopfer; A Hutchings; A Nixon; M T Petrucci
Journal:  Leukemia       Date:  2013-06-20       Impact factor: 11.528
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.